超短波辅助治疗成人支原体肺炎患者的效果

The Effect of Ultra Short Wave Assisted Treatment on Adult Patients with Mycoplasma Pneumonia

目的探讨超短波辅助治疗在支原体肺炎患者的应用效果。方法随机选取2019年6月—2023年9月山东健康集团新汶中心医院接受治疗的80例成人支原体肺炎患者为研究对象,根据随机投币法分为接受常规治疗的对照组(n=40)和在常规治疗基础上接受超短波治疗的观察组(n=40),比较两组患者的临床症状消退时间、肺功能、炎症因子水平及凝血功能。结果观察组退热时间、咳嗽缓解时间、咳痰缓解时间、肺部啰音消失时间以及胸片病灶吸收时间均短于对照组,差异有统计学意义(P均<0.05)。治疗14 d后,观察组的最大呼吸流量(190.23±5.57)L/min、第1秒末用力呼气容积(2.49±0.32)L、用力肺活量(2.77±0.53)L均高于对照组,差异有统计学意义(t=-9.419、-4.605、-5.219,P均<0.05);治疗14 d后,观察组肿瘤坏死因子-α(17.58±3.06)ng/L、降钙素原(0.64±0.13)ng/L、白细胞介素-6(28.87±3.51)pg/mL、C反应蛋白(10.74±1.76)mg/L均低于对照组,差异有统计学意义(t=4.684、8.705、8.308、4.459,P均<0.05);治疗14 d后,观察组血小板计数(201.31±42.16)×10^(5)/L、D-二聚体(0.51±0.13)mg/L均低于对照组,差异有统计学意义(t=2.679、7.339,P均<0.05)。结论超短波辅助治疗可降低成人支原体肺炎患者的炎症因子水平,改善肺功能和血液循环状态,有利于缩短临床症状消退时间。

Objective To explore the application effect of ultra short wave adjuvant therapy in patients with Mycoplasma pneumonia.Methods A total of 80 adult patients with mycoplasma pneumonia who received treatment in Shandong Health Group Xinwen Central hospital from June 2019 to September 2023 were randomly selected as the study objects,and were divided into control group(n=40)receiving conventional treatment and observation group(n=40)receiving conventional treatment according to random coin-operated method.The clinical symptom resolution time,lung function,inflammatory factor level and coagulation function were compared between the two groups.Results Fever remission time,cough remission time,sputum remission time,lung rales disappearance time and chest radiographic lesion absorption time in observation group were shorter than those in control group,the differences were statistically significant(all P<0.05).After 14 days of treatment,the maximum respiratory flow rate was(190.23±5.57)L/min,forced expiratory volume was(2.49±0.32)L at the end of the first second and forced vital capacity was(2.77±0.53)L in the observation group,which were higher than those in the control group,the differences were statistically significant(t=9.419,4.605,5.219,all P<0.05);after 14 days of treatment,tumor necrosis factor-αwas(17.58±3.06)ng/L,procalcitonin was(0.64±0.13)ng/L,interleukin-6 was(28.87±3.51)pg/mL and C-reactive protein was(10.74±1.76)mg/L in observation group,which were lower than those in control group,the differences were statistically significant(t=4.684,8.705,8.308,4.459,all P<0.05).After 14 days of treatment,the platelet count was(201.31±42.16)×10^(5)/L and D-dimer was(0.51±0.13)mg/L in observation group,which were lower than those in control group,and the differences were statistically significant(t=2.679,7.339,both P<0.05).Conclusion Ultrashort wave adjuvant therapy can reduce the level of inflammatory factors in adult patients with mycoplasma pneumonia,improve lung function and blood circulation,and shorten the time of clinical symptoms.